Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven...
Diagnostics
Nano Positioning Systems Market to Grow by USD 183.95 Million (2024-2028), Driven by Nanotechnology & Market Evolution Powered by AI – Technavio
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global nano positioning...
Huxley Medical Announces FDA Clearance for Cellular-Enabled SANSA Home Sleep Apnea Test
ATLANTA, Feb. 5, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and...
UMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testing
BOSTON, Feb. 5, 2025 /PRNewswire/ -- Volta Labs, a leading genomics applications company, and UMC Utrecht, one of the largest public...
Comma Raises $2M Seed Round to Bring Personalized Science to Reproductive Health
The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/...
New Functional Medicine Practice, Aura Functional Medicine, Offers Holistic, Root-Cause Focused Healthcare to the Boulder, Colorado Area
Functional medicine expert and naturopathic doctor, Dr. Alison Egeland, has launched Aura Functional Medicine, a new practice that applies the...
Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic...
Celebrating the Winners of the Inaugural Sony Women in Technology Award with Nature
NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ -- Sony Group Corporation (Sony) and Nature are proud...
Mass Spectrometry Market to Hit USD 9.62 Billion by 2030 with 7.2% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Feb. 4, 2025 /PRNewswire/ -- The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted...
Axtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSR
GenAI-powered solution delivers clinical study reports in minutes with 30%–50% faster turnarounds, 90% ICH-E3-aligned accuracy, and substantial cost savings. BERKELEY...
PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI
Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin...
Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
According to the report: up to 75% of women will have at least one vaginal yeast infection in their life...
Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members
Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effort to advance cancer immunotherapy...
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
YOKNEAM, Israel, Feb. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today...
Notal Vision Announces a Pivotal Study Demonstrating the Efficacy of AI in Enabling Home OCT Monitoring
Manassas, Virginia--(Newsfile Corp. - February 3, 2025) - Digital healthcare provider, Notal Vision, announced that the results of a pivotal...
Women in Science: Breaking Barriers with HNL Lab Medicine
ALLENTOWN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Women are still vastly underrepresented in science, technology, engineering, and math (STEM)...
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying...
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered...
Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Jan. 30, 2025 /PRNewswire/ -- The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted...
VMX 2025: A Record-Breaking Celebration of Innovation, Education and Thought Leadership in Veterinary Medicine
Breakthroughs in veterinary medicine, immersive hands-on experiences and Academy Award-winning actor and director Kevin Costner headline the world's largest and...